Total Pageviews

Thursday, March 31, 2011

Enercon dispute and future of joint ventures

Joint ventures would not be same in future, the Enercon dispute is an inflection point. Read the post by Prashnat Reddy.
Why did not Enercon GmBH promote fully owned subsidiary in India as done by many MNCs to protect & leverage their IP?

INPEX invention & new product exposition

INPEX 2011 is scheduled from June 14-17th 2011 at Pittsburgh, USA. 
This year a special package to Indian Innovators is available. 
Contact Anjan Dey,, 0933 127 9199 for details.

Monday, March 28, 2011

The New Multinationals: perspectives from Spain

The popular model of MNC's global expansion vertically and horizontally is well document.For horizontal expansion, technology and brands are considered pre-requisites. The raise of multinationals from developing nations like India puzzled many. In this book Mauro F. Guille´n and Esteban Garc─▒´a-Canal , develop a new theory of enablers for new MNCs. The examples were mostly Spanish but might be valid for Indian MNCs too.
The new multinationals from the BRIC countries have made great inroads into the global economy. Among Brazilian firms, Companhia Vale do Rio Doce and Metalu´rgica Gerdau are among the largest firms in mining and steel, Embraer holds with Bombardier of Canada a duopoly in the global regional jet market, and Natura Cosme´ticos has a presence in both Latin America and Europe. Lukoil, Gazprom, and Severstal are among the Russian multinationals, while India boasts an army of firms not only in IT and outsourcing services, in which companies such as Infosys, TCS, and Wipro are among the largest in the world, but also in steel, automobiles, and pharmaceuticals. Chinese firms have erupted with force in global markets not only as exporters but also as foreign investors, and in every industry from mining and oil to chemicals and steel. In electrical appliances and electronics, China boasts three increasingly well-known firms: Haier, Lenovo,and Huawei.
International expansion for new MNCs has become possible due to unique capabilities developed by them in their home country in less than perfect conditions.The process of resource accumulation is dependent on home country characteristics such as:
1. infrastructure gaps created opportunities leading to project execution capabilities- Bharati Telecom, GMR Airports, Adani shipyards.
2. Managing suffocating regulations and red tape became a source of competitive advantage as firms learn to leverage previliged political connection.- Reliance
3. Managing fragmented and relatively low capacities at home made the new MNCs masters in turning around under performing firms in foreign countries- Birla empire. 
4. meeting unconventional needs at home developed expertise in specific niches carried to global niches- pharma generics,frugal innovations. 
5. joint ventures and technology transfer arrangements upgraded engineering skills- Tata Motors. 
6. working with Fortune 500 firms resulted in reputation- IT giants.


Tuesday, March 22, 2011

Indian technology licensee for Mosquito control left in the cold by regulatory authority

Rajagopalan in the current science narrates sorrowful state of technology transfer from Indian research institutes. The Vector Control Research Institute under Ministry of Health and Family Welfare developed bio-friendly Mosquito Control agent and with approval from WHO license the same. Now comes the shock- another agency under the same ministry , National Vector Borne Disease Control Programme (NVBDCP) rejects this product. Read:

Hans Rosling's 200 Countries, 200 Years, 4 Minutes - The Joy of Stats - ...

DNA of biopreneur

Check out this SlideShare Presentation:

Monday, March 21, 2011

How much it costs to develop a new drug?

What is the cost of developing a new drug ( new chemical entity/new molecular entity) ? 
MNCs quote $1.32 billion and this is based on estimate of $802 million in 2000. 
While not denying Drug discovery is expensive and long drawn, the estimates were always taken with disbelief. 
Now read this from David.

IDG Chairman On India Fund Strategy & Chinese Venture Exits

Innoget Challenge: Ethernet Switch Hardware

University research group focused in Advance Ethernet Switching actively developping and promoting layer two protocols for campus enterprise and data center networks
CHALLENGE DESCRIPTIONBasic mechanism of ARP Path protocol operates as follows:
A broadcast Ethernet frame arrives at a port of a bridge, where its source address SA, if unkown to the bridge, gets associated to that port and this association remains locked (can not change) for some short time (i.e. 10 milliseconds). Frames with same source address SA arriving to other ports (thus arriving via a port that is not associated to SA address) are discarded.
It must be implemented in hardware and, whenever possible, be applicable to large Ethernet switches with ports located at multiple line boards, taking into account that many frames arrive simultaneously to all ports of the bridge.

Friday, March 18, 2011

Global Innovation Commons

The Global Innovation Commons, is a repository of innovations that can be used because of patent expiration, abandonment, invalidity, or lack of in-country protection.Patent repositories are available for Agriculture, Water, Clean Energy, World Health. Checked Snake Bite- 88 patents are listed , most not do not have an equivalent patent enforced in India. Top of list is Patent `

Tuesday, March 15, 2011

webinar on Patenting by Artcle one partners

To help increase patent knowledge and research skills, Article One will be running an exciting educational webinar next week. The team of experts will be presenting on a variety of topics, including:
· Patent basics
· Prior art research techniques
· Tips for how to succeed with Article One

The webinar will be held on Thursday, March 24th at 11:00 am (EST). If you are not able to attend, please register and we will send you a recording of the webinar. There will be a Questions and Answers session at the end of the webinar, so please bring your patent and IP questions!

You can register for the webinar here:

Technologies from Spain for the Hyderabad Technology Show on 17th March

UNIVERSIDAD DE ALICANTE, Spain shortlisted the following technologies for offer:
  • Method for obtaining polysubstituted pyrrolidines with Hepatitis C inhibiting activity,
  • Production of Trans-Resveratrol by grapevine cell suspensions,
  • Customized organic chemistry: Production and Process Research and Development in Fine Organic Chemistry,
  • Synthesis and Characterization of Bioadhesives for Surgery,
  • Weighted suit to enhance muscle development,
  • Synthesis of chemicals by electrochemical technology,
  • One-step paired electrochemical synthesis of L-cysteic acid and L-cysteine,

Plurodrive innovator Jaidip Shah is looking for business partners

Innovator of Plurodrive- a mechanical power transmission device for non automotive application, backed by patents, trademark and several installations is looking for a business partner with Pan India presence to aggressively promote the product.
Contact person: Jaidip Shah, jaidipshah@gmail.

Monday, March 14, 2011

Technologies from Hungary for the Hyderabad Technology Show of 17th March

Hungarian firm Laser Consult shortlisted 8 technologies for the Hyderabad Technology show scheduled on 17th March. They are:
1. Treatment of gastrointestinal disorders associated with enhanced motility and inflammation using kynurenic acid,
2. “Flow-less” 5-differential hematology analyzer.

3. Bio-compatible bone plug,
4. Novel digital dermoscopy device
5. A natural preparation for the relief of anxiety

6. Herbal human parasite elimination program
7. Special seating and positioning tilt-in-space wheelchair
8. Spine stabilizing implant family

Novel Genetic Engineering and Genome Mapping Techniques for Routine Molecular Diagnostics and Innovative Research Applications

Researcher Pulkit Sharma developed a unique protein production and synchronization process that is useful for all types of applications using a single product that can be customized to work on a variety of platforms as required by the end user. It is the only technique that can offer gene sequencing, gene therapy, and genetic identification (SNPs and FISH) on a single platform which can be adapted to meet various requirements of different end users. It also includes genetic engineering on via precise and efficient manipulation of the target genome.


World's Smallest Electric Bike,Moosshiqk , (E Bike)

Saturday, March 12, 2011

Probiotic Dahi for cardiovascular health, protection against cancer and improvement of immunity

License available from NDRI for this technology. Brief details:

Screened several strains of Lactobacillus acidophilus and Bifidobacterium bifidum for probiotic attributes including their ability to survive acidity in stomach and bile salts in the intestine, adhere to mucosal cells in the large intestine, and possess good bile salt hydrolase and antibacterial activity. The technology of Acido-bifidus probiotic dahi was developed incorporating selected strains of these two probiotic bacteria alongwith dahi culture (Lactococcus lactis ssp. cremoris and Lactococcus lactis ssp diacetylactis).  The culture conditions were worked out for development of the product that has flavor, taste and texture similar to that of regular Dahi. The counts of each of the two probiotic bacteria in the product are in the range 2x10 7 to   2x108 cfu/gram. Health benefits of the product have been validated, and the results published in 8 peer reviewed international journals. Acido-bifidus dahi improves cardiovascular health by lowering serum cholesterol levels.  It protects against intestinal cancer by decreasing the activation of carcinogens and improving their detoxification, and modifying the expressions of oncogenes and apoptotic genes. Acido-bifidus dahi slows down the ageing process by improving immunity (macrophage and lymphocyte functions) and antioxidant status. The health benefits of lactobacilli are strain specific and Acido-Bifidus probiotic dahi is a superior product compared to similar product available in the market, since these products document no health-benefit claims.

Patent applied: A process for preparation of Acido-bifidus probiotic Dahi. (Dr. V.K.Kansal, Ms. Sonal Rajpal). Application No. 639/DEL/2007 dated 23/03/2007

Other technologies on license from NDRI:

Contact person: V. K. Kansal, Principal Scientist, Division of Animal Biochemistry,
National Dairy Research Institute, Karnal-132001 (Haryana),
Ph: 9896914082, 0184-2259124 (O) , 0184-2203391(R)

Thursday, March 10, 2011

Technology Transfer 2011 Hyderabad

About 90 technologies in Life Science sector ( Pharma, medical equipment etc) scouted from across the globe will be on offer in the 1st Technology Transfer show planned at Hyderabad on 17th March. Venue Hotel Fortune Katriya,Somaji Guda, Opp Yashoda Hospital. Contact Sourabh 9347345392. 

Monday, March 07, 2011

Call For Inventors: The 2011 DiabetesMine™ Design Challenge

The DiabetesMine, a web resource for diabetics, is calling for innovative solutions to better the lives of persons with diabetes in its 2011 DiabetesMine Design Challenge.

This is the third year of the Challenge, which calls for new devices, web applications, or other instruments designed to facilitate the daily challenges that persons with diabetes face.  These include special diets, limitations to exercise, insuring proper blood circulation, blood sugar 
testing, insulin shots, blood pressure

Ideas can come from patients, parents of diabetic children, design, medical, and engineering students or professionals, or anyone else with knowledge of the disease that can come up with an ingenious groundbreaking concept.
There will be three grand prize winners, each receiving $7,000 in cash plus, guidance and support from a variety of innovation and investment professionals.  Two other finalists, the Most Creative Idea, and the Best Kids Concept will be awarded $2,500 and $1,500 respectively.
Projects will be submitted online at the Diabetes Mine website and 10 finalists will be selected by open community voting.  Winners will be selected by a distinguished panel of judges. The deadline for submissions is Friday, April 29, 2011, at 11:59 pm Pacific time

For complete information about the Challenge, visit Diabetes Mine.
(source: Myra Per-Lee)

Fostering a Creative Environment -- Filmed at Solutionman's Original Th...

Friday, March 04, 2011

Tech Transfer 2011- a technology roadshow (Pharma, Biotech & Medical Device) at Vizag, Hyderabad, Ahmedabad,Vadodara

After the phenomenal success of Tech Transfer 2010 - INDIA’S 1st ever technology roadshow, SkyQuest Technology Consulting (SkyQuest) in Association withFoundation for MSME Clusters (FMC) is planning a series of Technology Roadshows at National level in the month of March 2011. These Roadshows are conceptualized to promote National as well as International Technologies from Life Sciences sector aiming their commercialization and bridging the gap between the innovators and the Entrepreneurs. The four roadshows will offer the best marketplace to showcase & transact technologies spanning the major Pharma & Medical device clusters of India.

Industry Stakeholders could capitalize on their business needs through this one-of-its-kind Tech Roadshow 2011 platform. Moreover, for the first time ever the Innovators, of these novel technologies, will be available to directly present their technologies to potential buyers & interested parties. 
For more information   visit

These roadshows will spearhead the best IP marketplace at four different destinations across India in the month of March 2011.

15th - Vishakhapatnam | 17th - Hyderabad| 19th – Ahmedabad | 22nd - Vadodara   

Wednesday, March 02, 2011

10 month, non-residential , week end, Biopreneur program launched at EDI,Ahmedabad

A 10 month, non-residential Biopreneur program was launched at EDI,Ahmedabad on 28th Feb 2011. This activity is supported by Dept of Science and Technology, Government of India under Innovation Cluster program implemented by Foundation for MSME Clusters. DST of Gujarat govt is supporting this  under Gujarat State Biotechnology Mission.The program is intended for persons with strong entrepreneurial disposition, comfortable with new technologies and capable of raising investment of about Rs 500 lakhs. The participants would be receiving a bundle of consultancy services from technology selection to regulatory approvals. Course fee is Rs 45,000/- and commences in May 2011. Contact: Ms Nidhi Shah, Biopreneur Cell, EDI, 9979275056.

Tuesday, March 01, 2011

Sponsored research made more attractive with increase in weighted deduction to 200 percent- does that matter?

The current budget proposed enhancement of weighted deduction on payments made to National and Institutes of technology for Scientific research to 200% from 175%. Will that induce industry to sponsor more R&D on labs and IITs?  Taking CSIR case, Sponsored Research from Industry is clubbed with other government projects and shown as ECF (External Cash Flows). In 1996 vision document, a target of 7 billion rupees by 2001 was taken. And by 2003-4, ECF raised to Rs 2.55 billion.
As per CAG report 2007  `to generate ECF, a modernization plan of Rs 250 crores was approved in IXth plan, Rs 263 crores were actually spent but instead of generating a net positive incremental ECF of Rs 361 crores, that year under review resulted in negative incremental ECF of Rs 15 crores.
Any industry insights why/ why not sponsor R&D projects on CSIR or IITs? 

Kit for conversion of fossil fuel vehicles into Hybrid vehicles.

The Finance Minister said:
`In response to the growing demand for green ventures, a technology has been developed indigeneoulsy for the conversion of fossil fuel vehicles into Hybrid vehicles through the fitment of a kit. I propose to reduce the excise duty on such kits and their parts from 10% to 5%.'

Can anyone share information on the indigenous technology that caught the eye of Finance Minister?